Cargando…
l-carnitine, a friend or foe for cardiovascular disease? A Mendelian randomization study
BACKGROUND: l-carnitine is emerging as an item of interest for cardiovascular disease (CVD) prevention and treatment, but controversy exists. To examine the effectiveness and safety of l-carnitine, we assessed how genetically different levels of l-carnitine are associated with CVD risk and its risk...
Autores principales: | Zhao, Jie V., Burgess, Stephen, Fan, Bohan, Schooling, C. Mary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434903/ https://www.ncbi.nlm.nih.gov/pubmed/36045366 http://dx.doi.org/10.1186/s12916-022-02477-z |
Ejemplares similares
-
The associations of plasma phospholipid arachidonic acid with cardiovascular diseases: A Mendelian randomization study
por: Zhang, Ting, et al.
Publicado: (2021) -
Sex-specific Mendelian randomization study of genetically predicted insulin and cardiovascular events in the UK Biobank
por: Zhao, Jie V., et al.
Publicado: (2019) -
Dairy and cardiovascular health: Friend or foe?
por: Markey, O, et al.
Publicado: (2014) -
Mendelian randomization study on atrial fibrillation and cardiovascular disease subtypes
por: Kwok, Man Ki, et al.
Publicado: (2021) -
Thyroid function and ischemic heart disease: a Mendelian randomization study
por: Zhao, Jie V., et al.
Publicado: (2017)